Alpha Teknova, Inc. Profile Avatar - Palmy Investing

Alpha Teknova, Inc.

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and mo…

Drug Manufacturers - Specialty & Generic
US, Hollister [HQ]

Risk Factors

By Management
10-K
  1. Natural disasters (including earthquakes, fire, and drought), geopolitical unrest, war (including the war in Ukraine and the Israeli-Hamas war), terrorism, public health issues (like the COVID-19 pandemic) or other catastrophic events, some possibly related to the increasing effects of climate change, could disrupt the supply, production, delivery, or demand of our products, which could negatively affect our operations and performance.

  2. Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders and the federal district courts of the United States as the exclusive forum for litigation arising under the Securities Act, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us.

  3. Because we are a public company, we are obligated to develop and maintain proper and effective internal control over financial reporting in order to comply with Section 404 of the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act). These internal controls may not be determined to be effective, which may adversely affect investor confidence in us and, as a result, the value of our common stock.

Get PRO Today.

Read 22 more risk factors of Alpha Teknova, Inc.

End of TKNO's Analysis
CIK: 1850902 CUSIP: 02080L102 ISIN: US02080L1026 LEI: - UEI: -
Secondary Listings
TKNO has no secondary listings inside our databases.